← Open Payments lookup

ALLYSON MERCER: Open Payments

NPI 1154000156 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$759 in 45 payments from 12 companies in 2025. Trend: 2023 $348 · 2024 $1,026 · 2025 $759

Food & beverage: $751Education: $8
CompanyPaymentsAmount
ABBVIE INC.17$314
Supernus Pharmaceuticals, Inc.11$129
Otsuka America Pharmaceutical, Inc.5$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
Vanda Pharmaceuticals Inc.2$48
Tempus AI, Inc2$40
Axsome Therapeutics, Inc.1$27
Janssen Pharmaceuticals, Inc1$18
Alkermes, Inc.1$18
Neurocrine BioSciences, Inc.1$15

Products named: VRAYLAR, Qelbree, REXULTI, CAPLYTA, FANAPT, TEMPUS PIXEL, Auvelity, SPRAVATO.

Industry payments across TX — which companies pay providers there.